ClinConnect ClinConnect Logo
Search / Trial NCT06927323

Otago Exercise Program Combined With Action Observation Training in Stroke Patients

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Apr 7, 2025

Trial Information

Current as of August 20, 2025

Not yet recruiting

Keywords

Action Observation Training, Otago Exercises, Stroke, Gait, Balance

ClinConnect Summary

This clinical trial is studying how a combination of two types of exercises—Otago exercises and Action Observation training—can help improve balance, walking, and daily activities in people who have had a stroke. Stroke can make it hard for patients to maintain their balance and increases their chances of falling, so finding effective ways to help them regain their strength and stability is very important.

To participate in this study, individuals must be between the ages of 40 and 65, have experienced a stroke within the last two years, and be able to walk with or without assistance. They should also be able to understand the study's details and have a certain level of cognitive ability. Over the course of 12 weeks, participants will do targeted exercises three times a week to see if this training improves their balance and walking skills. The study will involve assessments before and after the intervention to measure any changes. This research aims to provide new insights into effective rehabilitation methods for stroke patients, enhancing their quality of life and reducing the risk of falls.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participants fulfilling given criteria will be included in this study
  • Both male and female participants will be included
  • The age limit for the participants will be 40-65 years
  • Sub-acute and chronic ischemic stroke up to 2 years.
  • Participants with BBS score between 35-40.
  • Participants having Montreal Cognitive Assessment (MoCA) score greater than 24 (out of 30).
  • Participants can walk with or without assistance.
  • Exclusion Criteria:
  • Participants having given criteria will be excluded from this study
  • Participants with other neurological diseases.
  • Participants who will not be able to understand the informed consent form.
  • Participants already involved in an exercise program for fall prevention.
  • Participants have no visual field defect, no abnormality in the vestibular organs, no orthopedic disease, and an unrestricted range of motion.

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Patients applied

0 patients applied

Trial Officials

Aruba Saeed, Phd

Principal Investigator

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported